Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
Saved in:
Main Authors: | Christina Jiang, BS, MS (Author), Susuana Adjei, MD (Author), Sueheidi Santiago, MD (Author), Jun Lu, MD (Author), Miguel Duran, MD (Author), Stephen Tyring, MD, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subtype transition from pemphigus vulgaris to pemphigus foliaceus
by: Ty Gilkey, BS, et al.
Published: (2023) -
Pemphigus vulgaris and foliaceus localized to the nose: Report of 2 cases
by: Mohannad G. Safadi, BS, et al.
Published: (2021) -
Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality
by: Khalaf Kridin, et al.
Published: (2017) -
Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris
by: Angela Y. Moore, MD, et al.
Published: (2023) -
From the Cochrane Library: Interventions for Pemphigus Vulgaris and Pemphigus Foliaceus
by: Ramiro Rodriguez, et al.
Published: (2023)